Top

Published in:

01-05-2020 | Coronavirus | Topic Review

Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology

Authors: Rohan Ramakrishna, Gelareh Zadeh, Jason P. Sheehan, Manish K. Aghi

Published in: Journal of Neuro-Oncology | Issue 3/2020

Abstract

The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions, this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here, we provide a framework for institutions and governments to help adjudicate treatment allocations to patients with neuro-oncologic disease.

The novel coronavirus outbreak: what we know and what we don't. Cell 180(6):1034–1036 (2020). https://doi.org/10.1016/j.cell.2020.02.027

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PG, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunubá Z, Fitz R, John KG, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30243-7 CrossRefPubMedPubMedCentral

Center JHC (2020) https://coronavirus.jhu.edu/map.html

Emanuel EJ, Persad G, Upshur R et al (2020) Fair allocation of scarce medical resources in the time of COVID-19. N Engl J Med. https://doi.org/10.1056/NEJMsb2005114 CrossRefPubMed

Surgeons ACo (2020) COVID-19: recommendations for management of elective surgical procedures. https://www.facs.org/covid-19/clinical-guidance

Burke JF, Chan AK, Mummaneni V, Chou D, Lobo EP, Berger MS, Theodosopoulos PV, Mummaneni PV (2020) Letter: the coronavirus disease 2019 global pandemic: a neurosurgical treatment algorithm. Neurosurgery. https://doi.org/10.1093/neuros/nyaa116 CrossRefPubMed

CMS (2020) https://www.cms.gov/files/document/31820-cms-adult-elective-surgery-and-procedures-recommendations.pdf

Florman JE, Cushing D, Keller LA, Rughani AI (2017) A protocol for postoperative admission of elective craniotomy patients to a non-ICU or step-down setting. J Neurosurg 127(6):1392–1397CrossRefPubMed

Laufer I, Rubin DG, Lis E et al (2013) The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 18(6):744–751PubMedPubMedCentral

10.

Cuomo A (2020) https://www.governor.ny.gov/news/no-20210-continuing-temporary-suspension-and-modification-laws-relating-disaster-emergency

11.

Patel ZM, Hwang PH, Nayak JV, Sajjadi H, Jackler RK (2020) Precautions for endoscopic transnasal skull base surgery during the COVID-19 pandemic. Neurosurgery

Title: Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology
Authors: Rohan Ramakrishna
Gelareh Zadeh
Jason P. Sheehan
Manish K. Aghi
Publication date: 01-05-2020
Publisher: Springer US
Keywords: Coronavirus
Glioma
Meningioma
Metastasis
Glioma
SARS-CoV-2
Care
Meningioma
COVID-19
Glioma
Published in: Journal of Neuro-Oncology / Issue 3/2020
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-020-03488-7

ACC 2024 Congress

Springer Medicine

Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology

Abstract

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2020

The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA)

Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma

RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping

GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma

Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis

High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients